BSX vs GEL · P/E 20, rev $10.65B vs rev $978.5M
Boston Scientific Corp (BSX) versus Genesis Energy LP (GEL) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Genesis Energy LP (GEL) is a oil & gas midstream company listed on NYSE.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported GEL revenue for 2026-06-30 was $978.5M. Net income was $49.7M. GEL currently screens at market cap $1.74B.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GEL currently screens at market cap $1.74B.
Not investment advice. Open the BSX and GEL stock pages for the full models.
Not investment advice.